Cited by 442Bone Metabolism and DiseasesSignaling Pathways in DiseaseNuclear Receptors and Signaling

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

The Role of NFAT in Osteoclast Formation

TAKAYANAGI, HIROSHI·2007·Annals of the New York Academy of Sciences

Open this paper in CoChat — free account

Abstract

Osteoclasts are cells of monocyte-macrophage origin that degrade bone matrix. Receptor activator of NF-kappaB ligand (RANKL) induces osteoclast formation in the presence of macrophage-colony-stimulating factor (M-CSF) and costimulatory signals. RANKL induces activation of the TNF receptor-associated factor 6 (TRAF6) and c-Fos pathways, which lead to the osteoclast-specific event, that is, autoamplification of nuclear factor of activated T cells (NFAT)c1, the master transcription factor for osteoclast differentiation. Autoamplification of NFATc1 is dependent on the calcium signaling of immunoglobulin-like receptors associated with immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors. In addition to the calcineurin-NFATc1 axis, calcium signaling activates the calmodulin-dependent kinase pathway, which also plays a critical role in osteoclast formation. Such advances in the understanding of the molecular mechanism of osteoclast differentiation are expected to lead to novel therapeutic approaches to bone diseases.

Integrity signals

Registry

Crossref · 10.1196/annals.1402.071

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Self-citation
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Self-citation
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720

Flagged first, then by citations

Show all 36 references

Sorted by citations

Osteoblast–osteoclast interactions
Chen, X., Wang, Z., Duan, N., Zhu, G., Schwarz, E. M., & Xie, C. L. (2017) · Connective Tissue Research · doi:10.1080/03008207.2017.1290085 · Cited by 905
Regulation of NFATc1 in Osteoclast Differentiation
Kim, J. H., & Kim, N. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.4.233 · Cited by 570
“This leads to their translocation from the cytosol to the nucleus, where they regulate the target genes.[21,22] There is a high degree of structural similarity among the different members of the NFAT family, which allows for redundancy in some NFAT functions in T cells.”
Background
The RANKL‐OPG system in clinical periodontology
Belibasakis, G. N., & Bostancı, N. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01810.x · Cited by 358
The Molecular Pathogenesis of Osteosarcoma: A Review
Broadhead, M. L., Clark, J. C. M., Myers, D. E., Dass, C. R., & Choong, P. (2011) · Sarcoma · doi:10.1155/2011/959248 · Cited by 355
FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1
Norrmén, C., Ivanov, K. I., Cheng, J., Zangger, N., Delorenzi, M., Jaquet, M., Miura, N., Puolakkainen, P., Horsley, V., Hu, J., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200901104 · Cited by 340
Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis
Saidak, Z., & Marie, P. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.009 · Cited by 339
Regulation of TNF-Induced Osteoclast Differentiation
Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280
“NFATc1 is the master transcription factor regulating OC differentiation [73,74], and thus, over-expression of NFATc1 results in the terminal differentiation and fusion of OCPs without adding RANKL [73,74], and can rescue the defect of RANKL- and TNF-induced OC formation caused by the deletion of NF-κB p50/p52 or c-Fos…”
Background
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 264
NFATc1: Functions in osteoclasts
Zhao, Q., Wang, X., Liu, Y., He, A., & Jia, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.018 · Cited by 241
Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups
Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., & Yu, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778078 · Cited by 241
RANKL-mediated Reactive Oxygen Species Pathway That Induces Long Lasting Ca2+ Oscillations Essential for Osteoclastogenesis
Kim, M. S., Yang, Y., Son, A., Tian, Y. S., Lee, S.-I., Kang, S. W., Muallem, S., & Shin, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051557 · Cited by 207
Podosome organization drives osteoclast-mediated bone resorption
Georgess, D., Machuca‐Gayet, I., Blangy, A., & Jurdic, P. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.27840 · Cited by 181
Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression
Zeng, X., He, L., Wang, S., Wang, K., Yue-yang, Z., Tao, L., Li, X., & Liu, S. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.85 · Cited by 170
Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives
Terkawi, M. A., Matsumae, G., Shimizu, T., Takahashi, D., Kadoya, K., & Iwasaki, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031786 · Cited by 174
Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species
Peng, J., Xu, Y. J., Zhang, Z. L., Li, K., Li, B., Zhang, W., & Yang, H. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22133 · Cited by 155
Cellular communications in bone homeostasis and repair
Nakahama, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0479-3 · Cited by 151
Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller
Racioppi, L., & Means, A. R. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.005 · Cited by 146
Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate
Fromigué, O., Haÿ, E., Barbara, A., & Marie, P. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110502 · Cited by 138
Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption
Kogawa, M., Findlay, D. M., Anderson, P., Ormsby, R. T., Vincent, C., Morris, H. A., & Atkins, G. J. (2010) · Endocrinology · doi:10.1210/en.2010-0334 · Cited by 138
Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease
Kajiya, M., Giro, G., Taubman, M. A., Han, X., Mayer, M. P. A., & Kawai, T. (2010) · Journal of Oral Microbiology · doi:10.3402/jom.v2i0.5532 · Cited by 135
Osteoclast formation and differentiation: an overview.
Soysa, N. S., Alles, N., Aoki, K., & Ohya, K. (2012) · PubMed · Cited by 126
Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling
Thummuri, D., Jeengar, M. K., Shrivastava, S., Nemani, H., Naik, R. R., Chaudhari, P. R., & Naidu, V. G. M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.006 · Cited by 125
MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα
Bae, S., Lee, M. J., Mun, S. H., Γιαννοπούλου, Ε., Yong‐Gonzalez, V., Cross, J. R., Murata, K., Giguère, V., van der Meulen, M. C. H., & Park‐Min, K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89935 · Cited by 123
Mechanotransduction activates α5β1 integrin and PI3K/Akt signaling pathways in mandibular osteoblasts
Watabe, H., Furuhama, T., Tani‐Ishii, N., & Mikuni‐Takagaki, Y. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.015 · Cited by 120
Transcriptional regulation of bone and joint remodeling by NFAT
Sitara, D., & Aliprantis, A. O. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00849.x · Cited by 120
Tmem64 Modulates Calcium Signaling during RANKL-Mediated Osteoclast Differentiation
Kim, H., Kim, T. S., Jeong, B., Cho, I., Han, D., Takegahara, N., Negishi‐Koga, T., Takayanagi, H., Lee, J. H., Sul, J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.002 · Cited by 118
Self-citation
TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-κB
Zhang, P., Liu, J., Xu, Q., Harber, G. J., Feng, X., Michalek, S. M., & Katz, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198085 · Cited by 116
STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription
Yang, Y., Chung, M., Zhou, S., Gong, X., Xu, H., Hong, Y., Jin, A., Huang, X., Zou, W., Dai, Q., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010139 · Cited by 113
New Perspective in Osteoarthritis: The OPG and RANKL System as a Potential Therapeutic Target?
Tat, S. K., Pelletier, J.-P., Velasco, C. R., Padrines, M., & Martel-Pelletier, J. (2009) · The Keio Journal of Medicine · doi:10.2302/kjm.58.29 · Cited by 112
Mechanisms involved in normal and pathological osteoclastogenesis
Park‐Min, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2817-9 · Cited by 126
Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation
Gu, Z., Wang, H., Xia, J., Yang, Y., Jin, Z., Xu, H., Shi, J., Domenico, I. D., Tricot, G. J. K., & Zhan, F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3804 · Cited by 107
Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation
Kim, J., Yang, J., Park, O.-J., Kang, S.-S., Kim, W., Kurokawa, K., Yun, C.-H., Kim, H., Lee, B., & Han, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1973 · Cited by 104
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
Zhou, L., Liu, Q., Yang, M., Wang, T., Yao, J., Cheng, J., Yuan, J., Lin, X., Zhao, J., Tickner, J. C., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2771 · Cited by 103
The role of Ca2+/Calcineurin/NFAT signalling pathway in osteoblastogenesis
Ren, R., Guo, J., Chen, Y., Zhang, Y., Chen, L., & Xiong, W. (2021) · Cell Proliferation · doi:10.1111/cpr.13122 · Cited by 105
A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL‐independent manner
Rifas, L., & Weitzmann, M. N. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24877 · Cited by 96
Calcium Signaling in Osteoclast Differentiation and Bone Resorption
Kajiya, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_41 · Cited by 98
S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll‐like receptor 4: Implications for bone destruction in murine antigen‐induced arthritis
Grevers, L. C., de Vries, T. J., Vogl, T., Abdollahi‐Roodsaz, S., Sloetjes, A. W., Leenen, P. J. M., Roth, J., Everts, V. E., van den Berg, W. B., & van Lent, P. L. E. M. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30290 · Cited by 98
Glucocorticoids mediate circadian timing in peripheral osteoclasts resulting in the circadian expression rhythm of osteoclast-related genes
Fujihara, Y., Kondo, H., Noguchi, T., & Togari, A. (2014) · Bone · doi:10.1016/j.bone.2013.12.026 · Cited by 99
Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling
Saidak, Z., Haÿ, E., Marty, C., Barbara, A., & Marie, P. J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00804.x · Cited by 94
Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
Kalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27200 · Cited by 90
The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in Osteoclasts
Léotoing, L., Wauquier, F., Guicheux, J., Miot-Noirault, É., Wittrant, Y., & Coxam, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068388 · Cited by 89
The functions and roles of sestrins in regulating human diseases
Chen, Y., Huang, T., Yu, Z., Yu, Q., Wang, Y., Hu, J., Shi, J., & Yang, G. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00302-8 · Cited by 85
The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity
Cao, Q., Zhang, J., Liu, H., Wu, Q., Chen, J., & Chen, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.020 · Cited by 84
Notch and the regulation of osteoclast differentiation and function
Yu, J., & CANALIS, E. M. (2020) · Bone · doi:10.1016/j.bone.2020.115474 · Cited by 83
Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion
Fang, C., Guo, J., Wang, Y., Li, X., Zhang, H., Cui, J., Hu, Y., Jing, Y., Chen, X., & Su, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00747-9 · Cited by 85
The effect of the degree of sulfation of glycosaminoglycans on osteoclast function and signaling pathways
Salbach‐Hirsch, J., Kliemt, S., Rauner, M., Rachner, T. D., Goettsch, C., Kalkhof, S., von Bergen�, M., Möller, S., Schnabelrauch, M., Hintze, V., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.028 · Cited by 81
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway
Wu, H., Hu, B., Zhou, X., Zhou, C., Meng, J., Yang, Y., Zhao, X., Shi, Z., & Yan, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0540-y · Cited by 81
Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro
Cantley, M. D., Fairlie, D. P., Bartold, P. M., Rainsford, K. D., Le, G. T., Lucke, A. J., Holding, C. A., & Haynes, D. R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22684 · Cited by 82
A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
Hong, G., Chen, Z., Han, X., Zhou, L., Pang, F., Wu, R., Shen, Y.-S., He, X., Hong, Z., Li, Z., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.392 · Cited by 78
Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12
Inui, M., Kikuchi, Y., Aoki, N., Endo, S., Maeda, T., Sugahara–Tobinai, A., Fujimura, S., Nakamura, A., Kumanogoh, A., Colonna, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900463106 · Cited by 77
Inhibition of Osteoclast Differentiation and Bone Resorption by N-Methylpyrrolidone
Ghayor, C., Correro, R. M., Lange, K., Karfeld‐Sulzer, L. S., Grätz, K. W., & Weber, F. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223297 · Cited by 80
TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation
Yamamoto, M., Gohda, J., Akiyama, T., & Inoue, J. (2021) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.97.009 · Cited by 76
Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
García-Gómez, A., Ocio, E. M., Crusoé, E. D. Q., Santamaría, C., Hernández‐Campo, P. M., Blanco, J. F., Sanchez-Guijo, F. M., Hernández‐Iglesias, T., Briñón, J. G., Fisac-Herrero, R. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034914 · Cited by 76
Orai1‐mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1
Hwang, S., & Putney, J. W. (2011) · The FASEB Journal · doi:10.1096/fj.11-194399 · Cited by 75
The Roles of Acidosis in Osteoclast Biology
Yuan, F., Xu, M., Li, X., He, X.-L., Fang, W., & Dong, J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00222 · Cited by 74
Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1 expression
Son, H. S., Lee, J., Lee, H. I., Kim, N., Jo, Y.-J., Lee, G., Hong, S.-E., Kwon, M., Kim, N. Y., Kim, H. J., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.004 · Cited by 72
Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide
Liu, F., Zhu, Z., Mao, Y., Liu, M., Tang, T., & Qiu, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.018 · Cited by 71
mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1
Huynh, H., & Wan, Y. (2018) · Communications Biology · doi:10.1038/s42003-018-0028-4 · Cited by 71
Investigating Osteocytic Perilacunar/Canalicular Remodeling
Yee, C. S., Schurman, C. A., White, C. R., & Alliston, T. N. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00514-0 · Cited by 76
Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
Kang, H., Kerloc’h, A., Rotival, M., Xu, X., Zhang, Q., D’Souza, Z., Kim, M. S., Scholz, J. A. C., Ko, J., Srivastava, P. K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.032 · Cited by 69
Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts
Egusa, H., Kaneda, Y., Akashi, Y., Hamada, Y., Matsumoto, T., Saeki, M., Thakor, D. K., Tabata, Y., Matsuura∥, N., & Yatani, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.032 · Cited by 69
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis
Zhao, Y., Ning, J., Teng, H., Deng, Y., Sheldon, M., Shi, L., Martinez, C., Zhang, J., Tian, A., Sun, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46602-3 · Cited by 69
Dopamine D2-like receptor signaling suppresses human osteoclastogenesis
Hanami, K., Nakano, K., Saito, K., Okada, Y., Yamaoka, K., Kubo, S., Kondo, M., & Tanaka, Y. (2013) · Bone · doi:10.1016/j.bone.2013.04.019 · Cited by 66
Scopoletin and Scopolin Isolated from Artemisia iwayomogi Suppress Differentiation of Osteoclastic Macrophage RAW 264.7 Cells by Scavenging Reactive Oxygen Species
Lee, S., Ding, Y., Yan, X., Kim, Y. H., & Jang, H. D. (2013) · Journal of Natural Products · doi:10.1021/np300824h · Cited by 66
Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy‐induced bone loss
Guan, H., Zhao, L., Cao, H., Chen, A., & Xiao, J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262055 · Cited by 64
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets
Zheng, H., Liu, Y., Deng, Y., Li, Y., Liu, S., Yang, Y., Qiu, Y., Li, B., Sheng, W., Liu, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00788-w · Cited by 69
Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways
Xu, Q., Chen, G., Liu, X., Dai, M., & Zhang, B. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.201 · Cited by 64
Benefits and mechanisms of polysaccharides from Chinese medicinal herbs for anti-osteoporosis therapy: A review
Lei, S. S., Su, J., Zhang, Y., Huang, X. W., Wang, X. P., Huang, M. C., Li, B., & Shou, D. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.11.030 · Cited by 62
The regulation of osteoclast differentiation by Wnt signals
Kobayashi, Y., Uehara, S., Koide, M., & Takahashi, N. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.82 · Cited by 63
Inhibition of T cell–dependent and RANKL‐dependent osteoclastogenic processes associated with high levels of bone mass in interleukin‐15 receptor–deficient mice
Djaafar, S., Pierroz, D. D., Chicheportiche, R., Zheng, X. X., Ferrari, S., & Ferrari‐Lacraz, S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27645 · Cited by 68
Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis
Baud’huin, M., Lamoureux, F., Jacques, C., Calleja, L. R., Quillard, T., Charrier, C., Amiaud, J., Berreur, M., Royer, B. B.-L., Owen, R., et al. (2016) · Bone · doi:10.1016/j.bone.2016.09.020 · Cited by 62
The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption
Kim, R. Y., Oh, J. H., Lee, B. S., Seo, Y., Hwang, S. J., & Kim, I. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.029 · Cited by 60
Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling
Mandal, C. C., Das, F., Ganapathy, S., Harris, S. E., Choudhury, G. G., & Ghosh‐Choudhury, N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668939 · Cited by 62
Cyanidin Chloride inhibits ovariectomy‐induced osteoporosis by suppressing RANKL‐mediated osteoclastogenesis and associated signaling pathways
Cheng, J., Zhou, L., Liu, Q., Tickner, J. C., Tan, Z., Li, X., Liu, M., Lin, X., Wang, T., Pavlos, N. J., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26126 · Cited by 59
Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways
Zhang, B., Yang, L., Ding, S., Liu, J., Dong, Y., Li, Y., Li, N., Zhao, X., Hu, C., Jiang, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01412 · Cited by 59
Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases
Zhu, S., Yan, M.-Q., Masson, A., Chen, W. "., & Li, Y. (2026) · Cell Discovery · doi:10.1038/s41421-025-00853-6 · Cited by 70
Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts
Kim, J., Kang, S., Kang, M., Gong, J., Lee, E., Han, S. J., & Kang, Y. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23351 · Cited by 58
Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways
Nepal, M. K., Choi, H. J., Choi, B.-Y., Yang, M.-S., Chae, J., Li, L., & Soh, Y. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.002 · Cited by 57
Effect of interleukin‐32γ on differentiation of osteoclasts from CD14+ monocytes
Kim, Y., Lee, C., Oh, J. S., Kim, S., Kim, K., & Yoo, B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27197 · Cited by 58
Lysosomal pH Plays a Key Role in Regulation of mTOR Activity in Osteoclasts
Hu, Y., Carraro‐Lacroix, L. R., Wang, A., Owen, C., Bajenova, E., Corey, P., Brumell, J. H., & Voronov, I. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25287 · Cited by 58
TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression
Zhao, Z., Hou, X., Yin, X., Li, Y., Duan, R., Boyce, B. F., & Yao, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135728 · Cited by 60
Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo
Hwang, Y.-H., Kim, K., Kim, S., Mun, S., Hong, S., Son, Y., & Yee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030912 · Cited by 57
Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression
Han, S., & Kim, Y.-K. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500228 · Cited by 54
Platinum Nanoparticles Suppress Osteoclastogenesis Through Scavenging of Reactive Oxygen Species Produced in RAW264.7 Cells
Nomura, M., Yoshimura, Y., Kikuiri, T., Hasegawa, T., Taniguchi, Y., Deyama, Y., Koshiro, K., Sano, H., Suzuki, K., & Inoue, N. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11099fp · Cited by 54
Silibinin inhibits prostate cancer cells‐ and RANKL‐induced osteoclastogenesis by targeting NFATc1, NF‐κB, and AP‐1 activation in RAW264.7 cells
KAVITHA, C. V., Deep, G., Gangar, S. C., Jain, A., Agarwal, C., & Agarwal, R. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21959 · Cited by 54
Different Blood‐Borne Human Osteoclast Precursors Respond in Distinct Ways to IL‐17A
Sprangers, S., Schoenmaker, T., Cao, Y., Everts, V. E., & de Vries, T. J. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25220 · Cited by 54
Macrophages and osteoclasts stem from a bipotent progenitor downstream of a macrophage/osteoclast/dendritic cell progenitor
Xiao, Y., Palomero, J., Grabowska, J. A., Wang, L., de Rink, I., van Helvert, L., & Borst, J. G. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017008540 · Cited by 52
A review on osteoclast diseases and osteoclastogenesis inhibitors recently developed from natural resources
Wang, X., Yamauchi, K., & Mitsunaga, T. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104482 · Cited by 54
Osteoclasts and Microgravity
Smith, J. K. (2020) · Life · doi:10.3390/life10090207 · Cited by 52
“NFATc1 binds to its own promoter, switching on an epigenetically controlled autoregulatory cycle that permits efficient induction of the osteoclast-specific genes, tartrate-resistant acid phosphatase (TRAP), cathepsin K, as well as the fusion-specific genes, dendritic cell-specific transmembrane protein (DC-STAMP) and…”
Background
Estrogen deficiency impairs integrin αvβ3-mediated mechanosensation by osteocytes and alters osteoclastogenic paracrine signalling
Geoghegan, I. P., Hoey, D. A., & McNamara, L. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41095-3 · Cited by 52
TRAF-6 Dependent Signaling Pathway Is Essential for TNF-Related Apoptosis-Inducing Ligand (TRAIL) Induces Osteoclast Differentiation
Yen, M., Hsu, P., Liao, H., Lee, B.-H., & Tsai, H.-F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038048 · Cited by 54
Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes
Verron, É., Loubat, A., Carle, G. F., Vignes‐Colombeix, C., Stražić, I., Guicheux, J., Rochet, N., Bouler, J., & Scimeca, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.015 · Cited by 51
Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling
Jiang, C., Xiao, F., Gu, X., Zhai, Z., Liu, X., Wang, W., Tang, T., Wang, Y., Zhu, Z., Dai, K., et al. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.002 · Cited by 51
Swine Atrophic Rhinitis Caused by Pasteurella multocida Toxin and Bordetella Dermonecrotic Toxin
Horiguchi, Y. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_206 · Cited by 49
Peroxiredoxin II Negatively Regulates Lipopolysaccharide-Induced Osteoclast Formation and Bone Loss via JNK and STAT3
Park, H., Noh, A. L. S. M., Kang, J., Sim, J.-S., Lee, D., & Yim, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5748 · Cited by 48
Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts
Georgess, D., Mazzorana, M., Terrado, J., Delprat, C., Chamot, C., Guasch, R. M., Pérez‐Roger, I., Jurdic, P., & Machuca‐Gayet, I. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0363 · Cited by 46
CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
Lee, D., Shin, K.-J., Kim, D. W., Yoon, K., Choi, Y., Lee, B. N. R., & Cho, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0562-5 · Cited by 49
The Role and Mechanism of miRNA-1224 in the Polygonatum sibiricum Polysaccharide Regulation of Bone Marrow-Derived Macrophages to Osteoclast Differentiation
Li, B., Wu, P., Fu, W., Xiong, Y., Zhang, L., Gao, Y., Deng, G., Zong, S., & Zeng, G. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2126 · Cited by 48
CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis
Huang, Y.-L., Chen, S.-T., Liu, R.-S., Chen, Y., Lin, C.-Y., Huang, C., Shu, P., Liao, C., & Hsieh, S.-L. E. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1409-0 · Cited by 47
The Bone Morphogenetic Protein Pathway: The Osteoclastic Perspective
Lademann, F., Hofbauer, L. C., & Rauner, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.586031 · Cited by 45

Authors: TAKAYANAGI, H.
Affiliations: Tokyo Medical and Dental University (JP)
Corresponding author: TAKAYANAGI, HIROSHI
ORCID: TAKAYANAGI, HIROSHI
Venue: Annals of the New York Academy of Sciences
Publisher: Wiley
Published: 2007-11
Volume: 1116
Issue: 1
Pages: 227-237
ISSN: 0077-8923 (ISSN-L)
1749-6632
DOI: 10.1196/annals.1402.071
OpenAlex: W1975505424
Cited by: 442
References: 36
Citations by year: 2026: 6 · 2025: 16 · 2024: 16 · 2023: 21 · 2022: 23 · 2021: 21 · 2020: 33 · 2019: 35 · 2018: 34 · 2017: 28 · 2016: 31 · 2015: 38 · 2014: 19 · 2013: 22 · 2012: 29
FWCI: 1.13
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 42 d)
Locations: Annals of the New York Academy of Sciences (publishedVersion)
PubMed (publishedVersion)
Funders: Kanae Foundation for the Promotion of Medical Science
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: osteoclastogenesis, NFATc1, RANKL, TRAF6, c-fos, calcineurin, calcium signaling, calcium/calmodulin-dependent protein kinase, ITAM, macrophage colony-stimulating factor, bone resorption, bone disease
MeSH terms: Animals, Humans, Osteoclasts, Transcription, Genetic, Signal Transduction, NFATC Transcription Factors, RANK Ligand

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of NFAT in Osteoclast Formation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks